Preferred Name |
belimumab |
|
Synonyms |
HGS-1006 Benlysta HGS1006 GSK1550188 GSK-1550188 LymphoStat-B BEL-114333 BEL114333 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C511911 |
|
altLabel |
HGS-1006 Benlysta HGS1006 GSK1550188 GSK-1550188 LymphoStat-B BEL-114333 BEL114333 |
|
cui |
C2980433 C1723401 C5226598 C5226596 C5226597 C1723402 |
|
HM |
D061067 |
|
Inverse of RB |
73B0K5S26A |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20140721 |
|
MeSH Frequency |
537 |
|
MMR |
20191031 |
|
notation |
C511911 |
|
PA |
D007166 |
|
PI |
*ANTIBODIES, MONCLONAL (2006-2013) |
|
prefLabel |
belimumab |
|
RR |
356547-88-1 (belimumab) |
|
SC |
1 |
|
Scope Statement |
monoclonal antibody directed against human BLyS protein (B lymphocyte stimulator) for treatment of autoimmune diseases |
|
SRC |
Curr Opin Investig Drugs 2006 May;7(5):464-72 |
|
TERMUI |
T678298 T000956318 T000967544 T000967543 T678299 T000967546 T000967542 T000967545 T000967541 |
|
TH |
NLM (2020) FDA SRS (2013) USAN (2003) NLM (2019) INN (19XX) NLM (2006) |
|
tui |
T116 T129 T121 |
Create mapping